On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions

dc.contributor.author	Puente García, Francisco Javier
dc.contributor.author	Gascón García-Ochoa, Fernando
dc.contributor.author	Ponte, Borja
dc.contributor.author	Fuente García, David Alfonso de la
dc.date.accessioned	2020-01-23T08:17:48Z
dc.date.available	2020-01-23T08:17:48Z
dc.date.issued	2019
dc.identifier.citation	Artificial Intelligence in Medicine, 100, p. 101703- (2019); doi:10.1016/j.artmed.2019.101703
dc.identifier.issn	0933-3657
dc.identifier.uri	http://hdl.handle.net/10651/53852
dc.description.sponsorship	Fernando Gascón would like to acknowledge financing from the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ref. MINECO-16-ECO2015-66184-R). Besides, the authors would like to thank the advice and help of Amparo García-Ochoa and Pepe García.
dc.format.extent	p. 101703-
dc.language.iso	eng
dc.relation.ispartof	Artificial Intelligence in Medicine, 100
dc.rights	© 2019 Elsevier
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072019243&doi=10.1016%2fj.artmed.2019.101703&partnerID=40&md5=6294eb0a498895e26244038b73f10ecf
dc.title	On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions
dc.type	journal article
dc.identifier.doi	10.1016/j.artmed.2019.101703
dc.relation.projectID	MINECO-16-ECO2015-66184-R
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.artmed.2019.101703

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.